These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8028630)

  • 21. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
    Lohrisch C; Paltiel C; Gelmon K; Speers C; Taylor S; Barnett J; Olivotto IA
    J Clin Oncol; 2006 Oct; 24(30):4888-94. PubMed ID: 17015884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant treatment in breast cancer.
    Powles TJ; Smith IE
    Lancet; 1992 Feb; 339(8790):423. PubMed ID: 1346673
    [No Abstract]   [Full Text] [Related]  

  • 23. Survival analysis of women with breast cancer under adjuvant therapy in South India.
    Venkatesan P; Raman TT; Ponnuraja C
    Asian Pac J Cancer Prev; 2011; 12(6):1533-5. PubMed ID: 22126494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic disease.
    Robinson AG; Turbin D; Thomson T; Yorida E; Ellard S; Bajdik C; Huntsman D; Gelmon K
    Clin Breast Cancer; 2006 Aug; 7(3):254-61. PubMed ID: 16942643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
    Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
    Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer.
    Truin W; Voogd AC; Vreugdenhil G; van der Sangen MJ; van Beek MW; Roumen RM
    Breast; 2011 Dec; 20(6):505-9. PubMed ID: 21665471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy in breast cancer.
    Del Mastro L; Costantini M; Bianco AR
    N Engl J Med; 1995 Aug; 333(9):596; author reply 597. PubMed ID: 7623914
    [No Abstract]   [Full Text] [Related]  

  • 28. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.
    Ursem CJ; Bosworth HB; Shelby RA; Hwang W; Anderson RT; Kimmick GG
    J Womens Health (Larchmt); 2015 May; 24(5):403-8. PubMed ID: 25884292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness and other assessments of adjuvant therapies for early breast cancer.
    Hillner BE; Smith TJ
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):129-34. PubMed ID: 8608043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The adjuvant chemotherapy of breast cancer].
    Semiglazov VF; Golubeva OM; Bavli IaL; Ivanova OA; Topuzov EE
    Vopr Onkol; 1992; 38(10):1187-94. PubMed ID: 1343144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy use and outcomes in older women with breast cancer: what have we learned?
    Silliman RA; Ganz PA
    J Clin Oncol; 2006 Jun; 24(18):2697-9. PubMed ID: 16782908
    [No Abstract]   [Full Text] [Related]  

  • 32. The prognostic implications of chemotherapy in the treatment of breast cancer.
    O'Brien ME; Smith IE
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):21-6. PubMed ID: 8777253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950-94.
    MacArthur AC; Le ND; Abanto ZU; Gallagher RP
    Occup Med (Lond); 2007 Jun; 57(4):246-53. PubMed ID: 17317704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of adjuvant therapy in the treatment of breast cancer.
    Levitt SH
    Strahlenther Onkol; 1995 Nov; 171(11):661-2. PubMed ID: 7502231
    [No Abstract]   [Full Text] [Related]  

  • 35. Study quantifies risk of breast cancer recurrence.
    CA Cancer J Clin; 2008; 58(6):322. PubMed ID: 18941122
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adjuvant chemotherapy in primary breast cancer].
    Harbeck N
    Onkologie; 2003 Dec; 26 Suppl 7():17-20. PubMed ID: 14716137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy in breast cancer.
    Newman MD
    N Engl J Med; 1995 Aug; 333(9):596; author reply 597. PubMed ID: 7623915
    [No Abstract]   [Full Text] [Related]  

  • 38. Is adjuvant chemotherapy omissible in women with T1-2 stage, node-positive, luminal A type breast cancer?
    Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Bae JS; Jung SS; Song BJ
    J Chemother; 2015 Oct; 27(5):290-6. PubMed ID: 25974160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer chemotherapy after fifty years: more cures and less mutilation.
    Greenspan EM
    Mt Sinai J Med; 1996; 63(3-4):250-5. PubMed ID: 8692172
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population.
    Rossi L; Stevens D; Pierga JY; Lerebours F; Reyal F; Robain M; Asselain B; Rouzier R
    PLoS One; 2015; 10(7):e0132853. PubMed ID: 26214853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.